Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Improving Fatigue and Depression in Individuals With Multiple Sclerosis Using Telephone-Administered Physical Activity Counseling.
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
Adult-Onset Leukoencephalopathies.
Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
Proceedings of the 6th Dubrovnik International Conference on Multiple Sclerosis, 10-12 May 2012, Dubrovnik, Croatia.
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis.
Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis.
A web-based decision support tool for prognosis simulation in multiple sclerosis.
Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
Computational modeling of cytokine signaling in microglia.
Prospective microglia and brain macrophage distribution pattern in normal rat brain shows age sensitive dispersal and stabilization with development.
[Programs for Continuing Medical Education: A session; 6. Advances in basic research and therapy of multiple sclerosis].
Orthopaedic Management of Spasticity.
Lyme disease associated neuroretinitis - Case report.
Rate and Predictors of Serious Neurologic Causes of Dizziness in the Emergency Department.
Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran?.
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration.
Pages
« first
‹ previous
…
563
564
565
566
567
568
569
570
571
…
next ›
last »